Metal-containing complexes have taken up center stage in the search for new cancer drugs that are as free of side effects as possible. In the journal Angewandte Chemie, a research team has now described how a very low dose ...
Biochemistry
Oct 12, 2022
0
44
Cancer is the second leading cause of death in Switzerland. Among the different types of cancers, non-small cell lung cancer (NSCLC) kills the most patients and remains largely incurable. Unfortunately, even newly approved ...
Cell & Microbiology
Oct 6, 2022
0
68
Researchers at the Paul Scherrer Institute PSI, in collaboration with ETH Zurich, have optimized a method for tumor diagnosis using radionuclides. Potential side-effects can now be significantly reduced through a molecular ...
Biochemistry
Oct 4, 2022
0
4
Stanford University researchers have discovered a rapid and sustainable way to synthetically produce a promising cancer-fighting compound right in the lab. The compound's availability has been limited because its only currently ...
Biochemistry
Oct 3, 2022
0
128
Carrier-free multi-component self-assembled nano-systems have attracted widespread attention owing to their easy preparation, high drug-loading efficiency, and excellent therapeutic efficacy. In an article recently published ...
Bio & Medicine
Sep 26, 2022
0
5
One approach to treating cancer is photodynamic therapy using photo-uncaging systems, in which light is used to activate a cancer-fighting agent in situ at the tumor. However, suitable agents must be stable under visible ...
Biochemistry
Sep 20, 2022
0
104
Newly discovered genetic commonalities and differences among the most prevalent types of canine soft tissue sarcomas, a common and potentially deadly tumor, could pave the way for more accurate diagnosis and better treatments ...
Veterinary medicine
Sep 14, 2022
0
5
Over the past 30 years, progress in early detection and treatment of cancer has helped reduce the overall death rate by more than 30%. Pancreatic cancer, however, has remained difficult to treat. Only 1 in 9 people survive ...
Bio & Medicine
Sep 13, 2022
0
199
A team led by University of Minnesota Twin Cities biomedical engineers has developed a universally accessible application that can simulate complex molecular interactions, which will allow researchers to design better treatments ...
Biotechnology
Sep 6, 2022
0
94
Researchers at Sanford Burnham Prebys, led by Ze'ev Ronai, Ph.D., have shown for the first time that inhibiting a key metabolic enzyme selectively kills melanoma cells and stops tumor growth. Published in Nature Cell Biology, ...
Cell & Microbiology
Sep 1, 2022
0
59
